Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer

Not yet recruitingOBSERVATIONAL

Enrollment

140

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2033

Conditions

Pancreatic Ductal Adenocarcinoma (PDAC)

Interventions

OTHER

Collecting biospecimens

Collecting blood, urine, tissue, and faecal samples

Trial Locations (1)

Linkou Chang Gung Memorial Hospital, Taoyuan District

All Listed Sponsors

lead

Chang Gung Memorial Hospital

OTHER

NCT07036978 - Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer | Biotech Hunter | Biotech Hunter